MaxCyte (United States) underperformed the market so far this year, based on data from August 7, 2025.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MaxCyte (United States) underperformed the market so far this year, based on data from August 7, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MaxCyte (United States)
Biotech company in Rockville, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksMaxCyte, Inc. (MXCT) Reports Q2 Loss, Misses Revenue Estimates MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compa